The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET ...

Global technology group Heraeus says in its ‘Precious Appraisal’ report that pharmaceutical platinum demand is expected to rise steadily moving forward. It explains that, with the World Health ...

Jan 17 (Reuters) - The U.S. Food and Drug ... of breast cancer who had received prior treatment. The list price of Datroway is $4,891.07 per vial, AstraZeneca said. It will be available to ...

Initially provided through the Cancer Drugs Fund (CDF) since January 2022, Osimertinib will now join the list of medicines ... lung cancer will be routinely available on the NHS." ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Just as targeted therapies and immunotherapies have revolutionized cancer treatment, mRNA-based approaches present ... the drugs. Over time, the treatment became more widely available, and the ...

The appearance of counterfeit drugs available online ... commercial success, their list of indications may also proceed to expand in kind. The potential benefits of GLP1-RAs for other conditions, from ...

Learn more about the event at www.virtualinvestorconferences.com.

In the wake of the Food and Drug Administration banning ... the synthetic color additive can cause cancer in animals. But the additive will still be present in some foods sold in the U.S. in ...

The dye is present in around 26 percent of ... some studies have found that the dye caused cancer in lab rats. Companies using the dye in drugs, such as cough syrups, will have until January ...